The Gene Therapy for Rare Disorders Conference focuses exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.
Incorporating insights from 50+ industry-leading speakers, this unique conference delves into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.